Evaluation of the effect of curcumin on pneumonia: A systematic review of preclinical studies. (5th November 2020)

• Record Type: Journal Article
• Authors: Alikiaii, Babak; Bagherniya, Mohammad; Askari, Gholamreza; Sathyapalan, Thozhukat; Sahebkar, Amirhossein
• Is Part Of: Phytotherapy research. Volume 35:Number 4(2021)
• Page Start: 1939
• Page End: 1952
• Publication Date: 2020-11-05
• Subjects: bacteria -- curcumin -- neutrophil -- pneumonia -- systematic review; Materia medica, Vegetable -- Periodicals; Botany, Medical -- Periodicals; Medicinal plants -- Periodicals; Plant Extracts -- therapeutic use -- Periodicals; Plants, Medicinal -- Periodicals; 581.634
• DOI: 10.1002/ptr.6939
• Languages: English
• ISSNs: 0951-418X

Abstract

Abstract : Pneumonia is a major cause of morbidity and mortality worldwide and causes a significant burden on the healthcare systems. Curcumin is a natural phytochemical with anti‐inflammatory and anti‐neoplastic characteristics. The aim of this study was to conduct a systematic review of published studies on the effect of curcumin on preclinical models of pneumonia. A comprehensive search was conducted in PubMed/Medline, Scopus, Web of Science and Google Scholar from inception up to March 1, 2020 to recognize experimental or clinical trials assessing the effects of curcumin on pneumonia. We identified 17 primary citations that evaluated the effects of curcumin on pneumonia. Ten (58.8%) studies evaluated the effect of curcumin on mouse models of pneumonia, generated by intranasal inoculation of viruses or bacteria. Seven (41.2%) studies evaluated the inhibitory effects of curcumin on the pneumonia‐inducing bacteria. Our results demonstrated that curcumin ameliorated the pneumonia‐induced lung injury, mainly through a reduction of the activity and infiltration of neutrophils and the inhibition of inflammatory response in mouse models. Curcumin ameliorates the severity of pneumonia through a reduction in neutrophil infiltration and by amelioration of the exaggerated immune response in preclinical pneumonia models.